» Articles » PMID: 39849087

Clinical Utility of Hematological Parameters in Aplastic Anemia

Overview
Journal Sci Rep
Date 2025 Jan 23
PMID 39849087
Authors
Affiliations
Soon will be listed here.
Abstract

Hematological parameters available on automated hematology analyzers have been shown to be useful indicators for hematological disorders. However, extensive studies especially in aplastic anemia for these indices are sparse. Our aim was to investigate the clinical utility of hematological parameters in aplastic anemia. The retrospective study included 146 patients with aplastic anemia and 150 normal controls matched in age and gender, where clinical characteristics and hematological parameters were classified and statistically analyzed. The study showed a statistical difference in the hematological parameters between aplastic anemia patients and controls. White blood cells, absolute neutrophil count, platelet, absolute reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, mean sphered cell volume, and light scattering reticulocyte count showed significant differences between non-severe aplastic anemia and severe aplastic anemia (p < 0.05). The analysis of the ROC curve showed that the hematological parameters were valuable for the differential diagnosis of severe aplastic anemia (areas under curve of white blood cell, absolute neutrophil count, platelet, absolute reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, mean sphered cell volume, light scatter reticulocytes were 0.620-0.859). Meanwhile, a combination of absolute neutrophil count, absolute reticulocyte count and mean sphered cell volume (AUC 0.893, 95% confidence interval 0.842-0.943, sensitivity 78.9%, specificity 85.7%) showed excellent precision for the differential diagnosis of severe aplastic anemia. Hematological parameters are readily available parameters that can be helpful to differentiate severe aplastic anemia from non-severe aplastic anemia. They may extend valuable prospects for clinical practice and research in aplastic anemia.

References
1.
Lohrmann H, Kern P, Niethammer D, Heimpel H . Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation. Lancet. 1976; 2(7987):647-50. DOI: 10.1016/s0140-6736(76)92462-4. View

2.
Zhang H, Huang Z, Wu X, Li Q, Yu Z . Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes. Life Sci. 2017; 189:71-75. DOI: 10.1016/j.lfs.2017.09.020. View

3.
Kulagin A, Lisukov I, Ivanova M, Golubovskaya I, Kruchkova I, Bondarenko S . Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol. 2013; 164(4):546-54. DOI: 10.1111/bjh.12661. View

4.
Hochsmann B, Rojewski M, Schrezenmeier H . Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes. Ann Hematol. 2011; 90(8):887-99. PMC: 3132386. DOI: 10.1007/s00277-011-1177-4. View

5.
Piva E, Brugnara C, Chiandetti L, Plebani M . Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med. 2010; 48(10):1369-80. DOI: 10.1515/CCLM.2010.292. View